脱细胞真皮基质在放疗后即刻乳房重建中的并发症率:单机构回顾性比较研究
该单机构回顾性研究纳入了2010至2019年间接受即刻乳房重建并放疗的130例患者,比较使用与不使用脱细胞真皮基质(ADM)的术后并发症率。结果显示,在术前放疗和术后放疗亚组中,ADM组与非ADM组在轻微和严重并发症率上均无显著差异,多变量分析亦未发现ADM与并发症风险相关(OR 0.83,95%CI 0.22-3.08,p=0.78)。尽管并发症率仍较高,但ADM在放疗区域并未增加总体并发症风险。
要点
- 放疗后即刻乳房重建中,ADM组与非ADM组的轻微和严重并发症率均无显著差异。
- 多变量分析显示ADM使用与并发症风险无关(OR 0.83,95%CI 0.22-3.08,p=0.78)。
- 放疗区域乳房重建的总体并发症率仍较高,需个体化评估ADM获益与风险。
核心结论
- 在放疗区域行即刻乳房重建时,使用ADM并未显著增加总体并发症率。
研究设计与样本
- 单机构回顾性比较研究,纳入2010至2019年接受即刻乳房重建并放疗的130例患者。
主要发现
- 术前放疗组(ADM 36例,非ADM 18例)轻微并发症率分别为25%和22%(p=1.00),严重并发症率分别为31%和22%(p=0.52)。
- 术后放疗组(ADM 53例,非ADM 23例)轻微并发症率分别为21%和26%(p=0.11),严重并发症率分别为21%和26%(p=0.61)。
- 多变量逻辑回归分析显示ADM组与非ADM组无差异(OR 0.83,95%CI 0.22-3.08,p=0.78)。
临床怎么用
- 在放疗区域行即刻乳房重建时,ADM的使用可根据患者具体情况个体化决定,不因担忧并发症而常规排除。
- 需告知患者放疗区域乳房重建总体并发症率仍较高,ADM的获益与风险需进一步研究。
局限性
- 回顾性单机构设计,样本量有限,随访时间不同,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of acellular dermal matrix (ADM) in immediate breast reconstruction (IBR) continues to rise despite ongoing concerns with respect to increased complication rates. While the indications for radiation continue to broaden, it is essential to critically evaluate ADM's performance in its context. The purpose of this study was to review complication rates between patients reconstructed with and without ADM, who underwent IBR and radiation. METHODS: A retrospective review was performed for patients undergoing IBR and radiation from 2010 to 2019. Postoperative outcomes were compared between patients with and without ADM. RESULTS: Over a 9-year period, 130 patients underwent IBR and radiation (42% preoperatively and 59% postoperatively). For patients with preoperative radiation (36 ADM and 18 non-ADM), the average follow-up was 312 and 296 days, respectively. In this group, there was no difference in minor complications (25% ADM, 22% non-ADM, and p = 1.00) or major complications (31% ADM, 22% Non-ADM, and p = 0.52). For patients with postoperative radiation (53 ADM and 23 non-ADM), the average follow-up was 544 and 748 days, respectively. There was no difference in minor complications (21% ADM, 26% non-ADM, and p = 0.11) or major complications (21% ADM, 26% non-ADM, and p = 0.61). Multivariable logistic regression analyses showed no difference between ADM and non-ADM groups (OR 0.83, 95% CI 0.22-3.08, and p = 0.78). CONCLUSION: Despite increasing literature supporting the use of ADM in breast reconstruction, postoperative outcomes following radiation remain poorly understood. In the present study, we report no difference in overall complication rates between breasts reconstructed with and without ADM in an irradiated field. Nevertheless, the complication rate remains high, and future studies will be required to determine whether ADM-associated complications in an irradiated field outweigh the purported benefits.
引用
- Stein MJ, Chung A, Arnaout A, et al. Complication rates of acellular dermal matrix in immediate breast reconstruction with radiation: A single-institution retrospective comparison study. J Plast Reconstr Aesthet Surg. 2020. PMID: 32561384. doi:10.1016/j.bjps.2020.05.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。